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Abstract: Introduction: The gut microbiota plays a role in gut–brain communication and can
influence psychological functioning. Diet is one of the major determinants of gut microbiota
composition. The impact of unpasteurised dairy products on the microbiota is unknown. In this
observational study, we investigated the effect of a dietary change involving intake of unpasteurised
dairy on gut microbiome composition and psychological status in participants undertaking
a residential 12-week cookery course on an organic farm. Methods: Twenty-four participants
completed the study. The majority of food consumed during their stay originated from the organic
farm itself and included unpasteurised milk and dairy products. At the beginning and end of
the course, participants provided faecal samples and completed self-report questionnaires on
a variety of parameters including mood, anxiety and sleep. Nutrient intake was monitored with
a food frequency questionnaire. Gut microbiota analysis was performed with 16S rRNA gene
sequencing. Additionally, faecal short chain fatty acids (SCFAs) were measured. Results: Relative
abundance of the genus Lactobacillus increased significantly between pre- and post-course time
points. This increase was associated with participants intake of unpasteurised milk and dairy
products. An increase in the faecal SCFA, valerate, was observed along with an increase in the
functional richness of the microbiome profile, as determined by measuring the predictive neuroactive
potential using a gut–brain module approach. Conclusions: While concerns in relation to safety
need to be considered, intake of unpasteurised milk and dairy products appear to be associated
with the growth of the probiotic bacterial genus, Lactobacillus, in the human gut. More research is
needed on the effect of dietary changes on gut microbiome composition, in particular in relation to
the promotion of bacterial genera, such as Lactobacillus, which are recognised as being beneficial for
a range of physical and mental health outcomes.
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1. Introduction
A growing body of evidence over the past decade has demonstrated the importance of the gut
microbiome in all aspects of physical and mental health. While it is still unclear what exactly constitutes
a ‘healthy’ gut microbiome, certain bacterial groups have been strongly associated with better health
outcomes. Lactobacillus is one of the foremost genera considered to have probiotic properties [1].
A probiotic is defined as a live microorganism which, when administered in adequate amounts,
confers a health benefit on the host [2]. The word ‘psychobiotic’ is an expansion of this term and
describes an organism that has been proven to be beneficial in relation to psychological functioning [3].
There have been a wide variety of studies undertaken in recent years that have demonstrated the
benefit of a Lactobacillus probiotic, both mono- and multi-strain, for improving a range of health
outcomes, including obesity [4], diabetes [5], liver disease [6], cardiovascular disease [7], gastrointestinal
conditions [8] and neuropsychiatric disorders, such as depression, anxiety and autism [9].
A key present-day challenge involves identifying the most effective ways of maintaining a healthy
gut microbiome and promoting the growth of probiotic bacteria. While commercial probiotic products
are widely available, there are concerns in relation to regulation, quality control, efficacy and cost [10].
Dietary intake is one of the main factors regulating gut microbiome composition and food-based
interventions can be tailored to each individual to modify their bacterial profile [11]. While unravelling
the diet–microbiome relationship is a formidable task given the many confounding factors, attempts
to do so have been made over the past decade. Gut microbiome profile has been shown to be
distinctly different in those living in rural areas with a traditional diet in comparison to urban-based
westernised populations [12–14]. Even when one accounts for contributions of human genetic and
geographical factors between populations, subsistence methods and diet significantly impact gut
microbiota composition [15]. It is hypothesised that a ‘microbiota insufficiency syndrome’ has resulted
from modern lifestyle with its highly processed diets, overuse of antibiotics and increased sanitation
and that the ‘industrialised’ microbiota may be a major contributing factor in the rise of many
non-communicable chronic diseases in westernised societies [16]. Even as one moves from looking at
the early ancestral microbiota to more recent times, significant changes in lifestyle have continued
until relatively recently. Ireland, as with many countries in the developed world, was a predominantly
agrarian society up until the mid-late 20th century. In 1966, over 30% of the workforce were employed
in agriculture, with this figure estimated at less than 5% in 2016 [17]. Consumption of unpasteurised
milk was a common part of the diet of those living on farms and epidemiological studies suggest that
it may have played a protective role against the development of allergies and atopic diseases [18].
Despite food safety concerns, the consumption of unpasteurised milk appears to be growing in
popularity [19,20]. To our knowledge, there are no studies exploring the impact of unpasteurised
milk intake on the gut microbiome. In this observational study, we investigated the effect of a dietary
change involving the intake of unpasteurised milk on gut microbiota composition, metabolites and
psychological status in 24 participants undertaking a residential, farm-based, 12-week cookery course.
Our centre had previously published a study [21] on the microbiota composition of unpasteurised milk
taken from Irish cows, which would thus be representative of the expected microbiota composition
of the raw milk that would be consumed by participants in our study. Given the reported high
proportion of viable probiotic bacteria such as Lactobacillus (and other LAB such as Lactococcus and
Leuconostoc), along with the fact that Lactobacillus are considered intrinsically resistant to gastric
acid [22], we hypothesised that a dietary change involving raw milk consumption would alter the gut
microbiome of participants with a potential differential increase in the relative abundance of these
probiotic bacterial groups.
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2. Methods
2.1. Study Site and Subjects
Ballymaloe Cookery School, Organic Farm and Gardens is located in East Cork, Ireland, and runs
bi-annual 12-week residential courses where students live on-site, learn about organic farming methods
and undertake intensive cookery classes. The majority of food consumed by participants during
their stay originates from the organic farm itself or consists of high-quality, locally-sourced produce.
The farm has a small herd of Jersey cows whose milk is used in its raw unpasteurised state for direct
consumption, cooking and the production of other dairy products including cream, butter, cheese and
yoghurt. There is an emphasis on eating, and cooking with, local seasonal fruit and vegetables, the vast
majority of which is organic. Meat and fish are also locally sourced and, for the most part, organic.
Approval of the study protocol was granted by the Clinical Research Ethics Committee of the
Cork Teaching Hospitals (Protocol number DOP001) and conducted following the ICH Guidelines on
Good Clinical Practice, and the Declaration of Helsinki. Written informed consent was obtained from
all subjects before study procedures were conducted. Course participants were emailed in advance
informing them of the study and a short talk on the gut microbiome was given at an introductory
session prior to commencement of the course. In order to be eligible for the study, participants had to
be between the age of 18–65 years and be generally healthy, with no chronic or current, physical or
mental illness. Exclusion criteria included the use of medications that were likely to interfere with
the objectives of the study (including any psychotropic medications) as well as intake of antibiotics,
probiotics or prebiotics within the month prior to commencement of the study.
2.2. Subject Metadata
Demographic data was collected for each individual including information on age, sex and race.
Weight and height were measured and used to calculate body mass index (BMI). Information in
relation to medical and psychiatric history, along with medication use, was also obtained at interview.
At the beginning and end of the 12-week course participants completed self-report questionnaires
on a variety of parameters including mood, anxiety, sleep, exercise (PSS, HADS, PSQI, International
Physical Activity Questionnaire (IPAQ)).
2.3. Diet Quantification
To monitor nutrient intake, participants completed the self-administered 152-item SLAN-06
(Survey of Lifestyle, Attitudes and Nutrition in Ireland) food frequency questionnaire (FFQ) [23],
which is validated to be used in an Irish population. An additional eight food items as well as questions
about type and frequency of milk, salt and fried food consumption were added. These items are
included in the EPIC Norfolk questionnaire [24] from which the SLAN-06 FFQ was adapted. An extra
section was added to the FFQ by the authors to quantify the intake of unpasteurised milk and dairy
products before and during the course, as this information would not otherwise have been captured.
These extra questions followed the same response format as the other food items.
Participants were asked to estimate the frequency with which they consumed a specified portion
size of each of the foods listed over the preceding month. The FFQ has nine possible responses ranging
from “never or less than once per month” to “6+ per day”. Participants completed the FFQ before and
after the stay at Ballymaloe. The FFQs were analysed for nutrient intake using the FETA software [25].
The 160 foods items were grouped into 29 food groups (e.g., fruits, vegetables, grains, sweets)
using methods similar to those described in previous studies of dietary patterns [26]. To estimate the
number of servings of any food group, each response was converted to the corresponding frequency
factor and summed over all the food items to get the average servings of a specific food group per day.
Intake of unpasteurised milk and dairy products was analysed in a similar way.
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2.4. Faecal Sample Collection and 16S rRNA Gene Sequencing and Processing
Faecal samples were collected at the beginning and end of the 12-week period in disposable
plastic containers with a Thermo Scientific™ Oxoid AnaeroGen 2.5 L Sachet in situ to generate
anaerobic conditions within the container. Participants were instructed to keep the sample containers
in a refrigerator at 4 ◦C. Samples were collected and transferred to a −80 ◦C freezer within 12 h.
DNA was extracted using the DNA Fast Stool DNA extraction kit (Qiagen, Hilton, Germany) using
the protocol for Gram positive bacteria and including an additional bead beating step at the beginning of
the procedure. DNA was quantified using the Qubit High Sensitivity Kit (Life Technologies, Carlsbad,
CA, USA), standardised and then used as a template for PCR. 16S metagenomic libraries were prepared
using primers to amplify the V3–V4 region of the bacterial 16S rRNA gene, with Illumina adaptors
incorporated as described in the Illumina 16S Metagenomic Library Preparation guide. Following
index PCR and purification, the products were quantified using the Qubit high sensitivity DNA kit
(Life Technologies) and pooled equimolarly. The pooled libraries were assessed using an Agilent high
sensitivity DNA kit and examined by quantitative PCR (qPCR) using the Kapa Quantification kit
for Illumina (Kapa Biosystems, Wilmington, MA, USA) according to the manufacturer’s guidelines.
Libraries were then diluted and denatured following Illumina guidelines and sequenced (2 × 300 bp)
on the Illumina MiSeq platform.
2.5. Sequence Table Generation
Three hundred base pair paired-end reads were prefiltered based on a quality score threshold
of >28 and trimmed, filtered for quality and chimaeras using the DADA2 library in R (version 3.6.3,
Vienna, Austria) [27]. Taxonomy was assigned with DADA2 against the SILVA SSURef database
release v132. Parameters as recommended in the DADA2 manual were adhered to unless mentioned
otherwise. ASVs were cut off at genus level, those that were unknown on the genus level were not
considered in downstream analysis, as were genera that were only detected as non-zero in five per
cent or fewer of total samples.
2.6. Short Chain Fatty Acid (SCFA) Measurements
The concentration of SCFAs, acetate, propionate, Iso-butyrate, butyrate, Iso-valerate, and valerate
were analysed by gas chromatography flame ionisation detection (GC-FID) using a Varian 3800 GC
system, fitted with a guard column (Restek) connected to an Agilent DB-FFAP column (30 mL × 0.3 m
ID × 0.25 µm df) and a flame ionisation detector with a CP-8400 auto-sampler.
2.7. Statistical Analysis
Statistical analysis for changes in dietary measures was performed using SPSS Statistical Packages
version 25 (SPSS, Inc., Chicago, IL, USA). Normality of outcome measures were assessed using Shapiro
Wilk’s test of normality. Differences in nutrient and food group intake pre- and post-course participation
were analysed using Student’s t-test or the non-parametric Wilcoxon Rank sum test.
Microbiome data-handling was done in R (version 3.6) with the Rstudio GUI (version 1.2.1555).
In all cases, the iNEXT library was used to calculate alpha diversity [28].
Principal component analysis (PCA) was performed on centred-log ratio transformed (clr) values
using the ALDEx2 library [29]. Number of permutations was always set to 1000. Aitchison distance
was used as a distance metric for beta-diversity. Piphillin [30] was used for functional inference from
16S rRNA gene sequences of stool samples in the form of Kyoto Encyclopedia of Genes and Genomes
(KEGG) orthologues. Gut–brain modules were calculated using the R version of the Gomixer tool [31].
Differential abundance of microbes between groups was assessed using the ALDEx2 library. As part
of testing for correlations between microbial abundance and metadata, skadi, an implementation of
jackknifing and Grubb’s test, was used to assess the reliability of the data and detect outliers (R scripts
available online, https://github.com/thomazbastiaanssen/Tjazi; [32]). Correlation was assessed using
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Spearmans’s rank correlation coefficient. The relationship between categorical variables was assessed
using Pearson’s Chi-squared test. For datasets in which the condition of normality was violated,
the non-parametric Kruskal–Wallis test was used and post-hoc analysis was done using the Wilcoxon
test. A p-value of <0.05 was deemed significant. To correct for multiple testing in tests correlating
volatility and specific microbiota, KEGG orthologues or pathways, the Q-value post-hoc procedure
was performed with a q-value of 0.1 as a cut-off [33].
3. Results
3.1. Participant Characteristics
A total of 62 participants who were completing the 12-week course between May and July 2018
were informed about the study. Twenty-eight participants volunteered and underwent screening.
Two were excluded; one had a chronic gastrointestinal disorder and another had taken antibiotics in the
previous month. Twenty-six participants were enrolled with 24 (13 females, 11 males) completing the
study; 2 failed to provide faecal samples. Of note, subject metadata and faecal samples were collected
within the first three days of the course and again at week 11. The final week of the course (week 12)
involved several examinations for students, and thus, the associated increased stress during this week
may have had the potential to influence findings. Baseline characteristics of participants, including
age, body mass index (BMI), smoking status, sleep quality and exercise levels are shown in Table 1.
Table 1. Baseline characteristics of participants.
Pre-Course Post-Course p-Value
Number of participants 24
Female; n (%) 13 (54)
Mean age; n (range) 30.25 (18–59)
Smoking status; n (%) 7 (29)
BMI (kg/m) 24.87 (3.42) 25.33 (3.61) 0.1
Physical activity (as measured by IPAQ score) 4757.52 (4614.74) 3271.52 (7280.05) 0.32
Sleep quality (as measured by PSQI) 5.36 (2.87) 4.95 (2.91) 0.25
Bristol stool scale score 3.78 (1.085) 4.04 (0.706) 0.39
GI-Visual Analogue Scale; Satisfaction with bowel habit 38.37 (33.757) 27.29 (27.98) 0.25
BMI: Body Mass Index, GI: Gastrointestinal, IPAQ: International Physical Activity Questionnaire; PSQI: Pittsburgh
Sleep Quality Index.
3.2. Changes in Diet
Based on food frequency questionnaire (FFQ) analysis (Tables 2 and 3), there was no change in total
calorie intake during the course. In terms of macronutrient intake, protein and carbohydrate intake
remained unchanged, and though total fat consumption increased, this change did not reach statistical
significance (mean increase (g) from 94 ± 35 to 128 ± 66, p = 0.08). With regards to micronutrients,
Vitamin A (µg) intake increased significantly (715 ± 577 to 1505 ± 975, p = 0.005) as did Vitamin B12
(µg) (7.8 ± 3.6 to 11 ± 5.8, p = 0.04). Although intake of fruit reduced slightly (2.02 ± 1.2 to 1.38 ± 0.84,
p = 0.04), consumption of vegetables and wholegrains did not change, nor did intake of alcohol or
unhealthy foods such as sweets or snacks.
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Table 2. Changes in dietary components between pre-course and post-course time points, obtained
from analysis of food frequency questionnaires. (p-values reaching statistical significance are in bold
and accompanied by an asterisk).
Nutrient Recommended Daily Intake Pre-Course Post-Course p-Value
Kilocalories 2000–2400 (males; depending onactivity level) 2264 ± 1006 2723 ± 1494 0.47
Protein (g) 10%–35% of total energy 97 ± 40 (17%) 109 ± 57 (16%) 0.54
Fat (g) 20%–35% of total calories 94 ± 35 (37%) 128 ± 66 (42%) 0.08
Carbohydrate (g) 45%–65% of total calories 246 ± 158 (43%) 275 ± 178 (40%) 0.77
Alcohol (mL)
21 standard drinks (1/2 pint of
beer, small glass of wine, one
measure of spirits)
15 ± 13 14 ± 13 0.98
Monounsaturated fatty acids (g) >12% of total energy 38 ± 17 (15%) 51 ± 27 (17%) 0.13
Polyunsaturated fatty acids (g) >6% of total energy 16 ± 7 (6%) 22 ± 13 (7%) 0.20
Saturated fatty acids (g) <10% of total energy 34 ± 13 (14%) 49 ± 25 (16%) 0.04 *
Cholesterol (mg) 300 mg 381 ± 173 469 ± 236 0.13
Total sugar (g) <10% of total energy 115 ± 67 (20%) 125 ± 76 (18%) 0.81
Starch (g) 128 ± 96 147 ± 104 0.62
Fibre (g) >25 g 19 ± 15 20 ± 15 0.88
Vitamin A (µg) 800 µg 715 ± 577 1505 ± 975 0.005 *
Thiamine (mg) 1.1 mg 1.8 ± 1.2 1.9 ± 1.2 0.87
Riboflavin (mg) 1.4 mg 2.3 ± 1.5 2.6 ± 1.7 0.45
Niacin (mg) 16 mg 27 ± 15 29 ± 19 1.00
Vitamin B6 (mg) 1.4 mg 3.1 ± 3.0 2.9 ± 1.9 0.81
Vitamin B12 (µg) 2.5 µg 7.8 ± 3.6 11 ± 5.8 0.04 *
Folate (µg) 200 µg 339 ± 284 328 ± 236 0.58
Vitamin C (mg) 80 mg 104 ± 60 79 ± 41 0.16
Vitamin D (µg) 5 µg 3.6 ± 2.3 5.1 ± 3.5 0.09
Vitamin E (mg) 12 mg 14 ± 7 16.6 ± 9.7 0.41
Phosphorous (mg) 700 mg 1612 ± 763 1787 ± 942 0.64
Calcium (mg) 1000 mg 914 ± 387 1062 ± 548 0.34
Iron (mg) 7 mg 15 ± 11 16 ± 11 0.81
Selenium (µg) 55 µg 67 ± 30 79 ± 43 0.49
Zinc (mg) 10 mg 12 ± 6 13 ± 7 0.58
Sodium (mg) 1600 mg 2983 ± 1559 3385 ± 1964 0.59
Potassium (mg) 2000 mg 3798 ± 1603 4015 ± 1958 0.85
Magnesium (mg) 375 mg 359 ± 200 343 ± 189 0.67
Copper (mg) 1 mg 1.2 ± 0.6 1.5 ± 0.8 0.31
Chloride (mg) 800 mg 4407 ± 2407 4885 ± 2886 0.64
Manganese (mg) 2 mg 3.1 ± 1.5 3.2 ± 1.8 0.85
Iodine (µg) 15 µg 169 ± 76 201 ± 100 0.28
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Table 3. Change in food group intake between pre-course and post-course time points, obtained from
analysis of food frequency questionnaires. (p-values reaching statistical significance are in bold and
accompanied by an asterisk).
Food Group Pre-Course Post-Course p-Value
Red meats 0.62 ± 0.35 0.85 ± 0.56 0.07
Processed meats 0.58 ± 0.77 0.33 ± 0.27 0.08
Poultry 0.31 ± 0.26 0.25 ± 0.22 0.73
Organ meats 0.04 ± 0.07 0.11 ± 0.09 0.01 *
Fish 0.55 ± 0.43 0.68 ± 0.49 0.04 *
Fried foods 0.21 ± 0.14 0.30 ± 0.16 0.03 *
Refined carbohydrates 0.84 ± 0.56 1.28 ± 1.17 0.26
Whole grains 0.66 ± 0.41 0.95 ± 0.75 0.29
Cereal 0.69 ± 1.45 0.47 ± 0.55 0.76
Potatoes 0.34 ± 0.26 0.49 ± 0.34 0.06
Pasta meals 0.42 ± 0.31 0.34 ± 0.25 0.66
High-fat dairy products 2.03 ± 1.15 3.59 ± 3.07 0.09
Low-fat dairy products 0.21 ± 0.27 0.36 ± 0.28 0.02 *
Egg dishes 0.61 ± 0.49 0.43 ± 0.29 0.34
Fruit 2.02 ± 1.2 1.38 ± 0.84 0.04 *
Green leafy vegetables 0.77 ± 0.42 1.25 ± 1.03 0.11
Cruciferous vegetables 0.68 ± 0.61 0.44 ± 0.32 0.34
Starchy vegetables 0.42 ± 0.56 0.37 ± 0.24 0.16
Other vegetables 3.98 ± 2.17 3.72 ± 2.03 0.66
Legumes 0.30 ± 0.24 0.22 ± 0.25 0.10
Sweets 1.77 ± 1.29 2.45 ± 2.00 0.31
Snacks 0.48 ± 1.00 0.37 ± 0.66 0.40
Soups 1.15 ± 1.24 1.11 ± 1.17 0.48
Sauces 0.19 ± 0.17 0.27 ± 0.28 0.31
Condiments 2.68 ± 1.65 3.17 ± 2.12 0.58
Non-alcoholic beverages 2.39 ± 1.71 1.99 ± 1.42 0.45
Alcoholic beverages 1.43 ± 1.21 1.42 ± 1.29 0.91
Fruit Juice 0.42 ± 0.71 0.39 ± 0.53 0.50
Sweetened beverages 0.81 ± 1.03 0.78 ± 0.74 0.56
Participants intake of milk and dairy products are summarised in Table 4. In relation to participants
overall intake of milk, this did not change during the course (mean increase from 177 ± 120 mls to
192 ± 134 mls, p = 0.60). However, a switch to unpasteurised milk was evident for most participants.
Only one of 24 (4%) participants reported consuming unpasteurised milk prior to commencing the
residential course while 23 participants (96%) reported its consumption during the course (mean
increase from 23 ± 116 mls to 239 ± 51 mls, p < 0.0001). Pre-course, 3 participants consumed skimmed
milk, 7 semi-skimmed, 11 whole and 3 non-specific and post-course only one participant consumed
semi-skimmed while the remaining participants consumed whole milk, consistent with unpasteurised
milk intake. Total intake of dairy products (cream, yoghurt, dairy desserts, cheese; salad cream or
mayonnaise, butter, cottage cheese) did increase slightly though not to a statistically significant level
(mean increase from 2.24 ± 1.23 daily servings to 3.35 ± 3.16, p = 0.07). Two participants (8%) reported
the intake of unpasteurised dairy products prior to the course whereas 21 (87.5%) consumed these
products during the course (mean increase from 0.01 ± 0.04 servings per day to 1.2 ± 1.4, p < 0.0001).
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Table 4. Change in participants consumption of milk and dairy products between pre-course and
post-course time points, obtained from analysis of food frequency questionnaires.
Dairy Intake Pre-Course Post-Course p-Value
Total Milk (mL) 177 ± 120 mls 192 ± 134 mls 0.6
High-fat dairy products (servings/day) 2.03 ± 1.15 3.59 ± 3.07 0.09
Low-fat dairy products (servings/day) 0.21 ± 0.27 0.36 ± 0.28 0.02 *
Total dairy products 2.24 ± 1.23 3.35 ± 3.16 0.07
Unpasteurised milk (mL) 23 ± 116 239 ± 51 <0.0001 *
Unpasteurised dairy products
(servings/day) 0.01 ± 0.04 1.2 ± 1.4 <0.0001 *
(p-values reaching statistical significance are in bold and accompanied by an asterisk).
3.3. Change in Microbiome Composition
We quantified the microbial diversity within each subject (α-diversity) before and after the course,
and the difference between each subject’s pre-course and post-course gut microbiota (β-diversity).
No significant differences were found in either α-diversity (Simpson; p = 0.41, Shannon; p = 0.26) or
β-diversity (p = 0.998) (Figure 1B,C). No differences were found between males and females.
Analysis of the differential relative abundance of bacterial taxonomic groups revealed a total of
578 amplicon sequence variants (ASVs) within our samples (Figure 1D). Undirected pairwise analysis
of all ASVs, (Wilcoxon signed rank test, allowing for Storey’s q-value post-hoc correction) revealed
only one ASV which changed significantly between pre-course and post-course time points. This ASV
corresponded to the genus Lactobacillus, which increased significantly (p = 0.0003728; q = 0.0498)
(Figure 1A). Identification of ASVs at a species level was not possible. We subsequently performed
a directed search in relation to other lactic acid bacteria (LAB), a dominant population in bovine
milk prior to pasteurisation based on what was previously reported in literature on the subject [21].
On the genus level, the relative abundance of Leuconostoc (p = 0.09) and Enterococcus (p = 0.14) did not
change but that of Lactococcus increased significantly (p = 0.01; q = 0.106). Other major components of
unpasteurised milk include Pseudomonas and Acinetobacter [21]. We did not detect these genera in any
of our samples.
We directly tested for associations between changes in dietary components and changes in
microbiome composition within each subject over time. We observed a positive correlation between
Lactobacillus abundance and combined intake of unpasteurised milk and dairy products (Spearman
correlation, r = 0.618, p = 0.0000027). Upon closer inspection, Lactobacillus abundance appeared to fall
into two groups based on the centred log-ratio (clr) transformation of relative abundance scores of >2.5
or <2.5, prompting us to dichotomise the data for Pearson’s Chi-squared test. We defined these groups
as low versus high Lactobacillus abundance and found a positive association between these two groups
and the change in intake of unpasteurised milk and dairy products (combined score), binned into four
groups based on the amount of portions consumed; 0–2, 3–4, 5–6 and 7–8. (Pearson’s Chi-squared,
X-squared = 13.265, df = 3, p-value = 0.004096) (Figure 2). This association also held when looking
at the relationship between Lactobacillus abundance and unpasteurised milk or unpasteurised dairy
products individually. We analysed this Lactobacillus grouping against our other metadata (including
age, sex, BMI, sleep, exercise and gastrointestinal parameters) but found no other factors associated
with the high versus low split.
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Figure 1. (A) Relative abundance of Lactobacillus at pre-course and post-course time points. (B) Alpha 
diversity of gut microbiome at pre-course and post-course time points. (C) Beta diversity of gut 
microbiome at pre-course and post-course time points. (D) Relative abundance of genus-level taxa for 
each participant. Each column represents one participant with pre-course taxa on the left and post-
course taxa on the right. (Box plots: Body represents median and interquartile range, whiskers represent 
the extreme values). 
Figure 1. (A) Relative abundance of Lactobacillus at pre-course and post-course time points. (B) Alpha
diversity of gut microbiome at pre-course and post-course time points. (C) Beta diversity of gut
microbiome at pre-course and post-course time points. (D) Relative abundance of genus-level taxa
for each participant. Each column represents one participant with pre-course taxa on the left and
post-course taxa on the right. (Box plots: Body represents median and interquartile range, whiskers
represent the extreme values).
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3.4. Functional Prediction and Application of Gut-Brain Modules
Functional analysis of our microbiome data was performed using Piphillin [30] and further
extended by subjecting our metagenomic data to a module-based analytical framework, which targets
microbial pathways involved in micr iota-gut-brain communication, thus generating a prediction
of the neuroactive potential of a microbiome sample [34]. Within our sample, we observed 43 of
the 56 gut-brain modules (GBMs) described previously by the authors. In addition, we observed an
increase in the functional richness of the microbiome profile, as determined by the number of gut–brain
modules (GBMs) present (Wilcoxon signed rank test; mean increase of 1.79, p = 0.00087) following
the 12-week course (Figure 3A). On analysis of the individual GBMs, one consistently increased
significantly; GBM026: Nitric oxide synthesis II (nitrite reductase) (p = 0.001; q = 0.061) (Figure 3B).
Notably, GBM004: Kynurenine synthesis was never found in participants pre-cours , but was detected
in 6 out of 24 participants post-course at very high levels. This observation did not pass the post-hoc
correction (p = 0.036, q = 0.361) (Figure 3C). Functional alpha diversity, measured here by calculating
the alpha diversity of the floored KEGG Orthologue tables generated by Piphillin, did not differ
between pre- and post-course time points (chao1; p = 0.14, Simpson; p = 0.19, Shannon; p = 0.85).
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Figure 3. (A) Functional richness of microbiome, as measured by observed number of gut–brain
modules (GBM) at pre-course and post-course time points. (B) Increase in abundance of GBM 026:
Nitric oxide synthesis II (nitrite reductase) between pre- and post-course time points. (C) Increase in
GBM 004: Kynurenine synthesis between pre- and post-course time points. (Box plots: Body represents
median and interquartile range, whiskers represent the extreme values; As some scores overlap,
each participant is not visible as an individual point on the graph. Yellow represents pre-course scores
and green represents post-course scores).
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3.5. Change in Microbiome Metabolites
Analysis of faecal short-chain fatty acids (SCFAs) revealed a significant increase in Valerate
(p = 0.049) over the 12 weeks. Propionate also increased, although not to a statistically significant level
(p = 0.08) while no change was observed in butyrate, iso-butyrate, iso-valerate or acetate (Table 5).
Table 5. Short-chain-fatty-acid (SCFA) concentrations; pre- and post-course results.
SCFA (µmol/g) Pre-Course Mean (SD) Post-Course Mean (SD) p-Value
Acetate 27.0 (8.6) 29.3 (10.3) 0.268
Propionate 14.0 (7.0) 16.3 (7.6) 0.091
Iso-butyrate 2.4 (1.1) 2.6 (0.9) 0.485
Butyrate 17.6 (9.6) 19.0 (10.8) 0.156
Iso-valerate 3.2 (1.9) 3.4 (1.7) 0.498
Valerate 2.3 (0.8) 2.5 (0.8) 0.049 *
Total BCFA 5.6 (2.9) 6.0 (2.5) 0.44
Total SCFA 66.6 (24.7) 73.1 (27.7) 0.113
p-values reaching statistical significance are in bold and accompanied by an asterisk. SD: Standard deviation.
3.6. Change in Psychological Measures
There was no change in total scores on the Cohen’s Perceived Stress Scale (PSS), Hospital Anxiety
and Depression Scale (HADS)-total score, HADS-anxiety subscale, HADS-depression subscale or
Pittsburgh Sleep Quality Index (PSQI) sleep quality score between pre- and post-course time points.
However, because our study involved a healthy population, baseline anxiety and stress scores were low
and mood scores were within the normal range. (Table 6) Further analysis was considered taking into
account baseline scores. The sample was dichotomised based on the median score of the above scales.
Participants with higher baseline scores on the PSS showed a mean reduction of 4.42 points, whereas
the rest of the participants reported a mean increase of 1 point (Mann–Whitney U test, p = 0.026)
between pre-course and post course time points. Participants with higher anxiety scores than the
median on the HADS-A also showed a statistically significant reduction compared to the rest of the
participants (mean reduction of 2.11 vs. a mean increase of 2.25, Mann–Whitney U test, p = 0.004).
We did not find any relationship between microbes and psychological scales. No differences were
found between males and females.




PSS 14.96 (6.23) 13.13 (5.12) 0.149
HADS-A 5.61 (3.72) 4.83 (3.21) 0.274
HADS-D 3.04 (2.82) 3.83 (3.42) 0.198







Change (Delta) between Pre- and
Post-Course Scores Mean (SD) p-Value
†
PSS-Highest 19.58 (3.12) 15.17(5.15) −4.42 (5.9)
0.026 *PSS-Lowest 10.08 (4.42) 10.91 (4.25) 1.0 (4.58)
HADS-A-Highest 7.67 (2.85) 5.56(3.44) −2.11 (2.30)
0.004 *HADS-A-Lowest 1.75 (1.17) 4 (2.35) 2.25 (2.30)
HADS: Hamilton Anxiety and Depression Scale, HADS-D: HADS-Depression subscale, HADS-A: HADS-Anxiety
subscale, HADS-T: HADS-Total score, PSS: Perceived Stress Scale, SD: Standard deviation. PSS-highest refers to those
participants with scores above the median and PSS-lowest to those with scores below the median. HADS-A-highest
refers to those participants with scores above the median and HADS-A-lowest, to those with scores below the
median. († the p-value in this case refers to the comparison between the mean scores of delta PSS-highest and delta
PSS-lowest as well as the mean scores between delta HADS-A-highest and delta HADS-A-lowest. p-values reaching
statistical significance are in bold and accompanied by an asterisk).
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4. Discussion
In this observational study, we investigated the effect of a dietary change on the gut microbiome
of participants who undertook a 12-week residential cookery course on an organic farm, where the
majority of food consumed and used for cooking, was locally-sourced, seasonal and produced using
organic methods. Of particular interest was the use of unpasteurised milk and dairy products obtained
from a small herd of Jersey cows on the farm. Most participants had not been using any unpasteurised
dairy prior to the course and all used these products to some degree throughout their stay. We found
that the main change in terms of microbiome composition was a dramatic increase in the participants’
Lactobacilli between pre-course and post-course faecal samples. This increase was strongly associated
with the participants’ intake of unpasteurised milk and dairy products. In addition, a positive change
was noted in relation to microbiome metabolites with an increase in valerate and, to a lesser extent not
quite reaching statistical significance, propionate.
While administration of probiotics in the form of conventional pharmaceutical agents such as
tablets or capsules is a common method, the majority of probiotics commercially available are in the
form of food-based delivery systems, which use probiotic bacteria in their production or add these
bacteria during the manufacturing process, for example, cheese, yoghurt or fermented drinks [35].
There are several problems associated with pharmaceutical and commercially-produced probiotic
formulations. Firstly, the probiotic potential of bacteria is species and strain-specific but efficacy is often
generalised across products in the current unregulated commercial probiotic market [36]. Secondly,
there are many aspects of the manufacturing process of such products, which can alter the delivery of
viable functional probiotic bacteria [37]. Because probiotic products are generally categorised as food
supplements, they are subject to less stringent regulatory criteria and quality control processes with
regard to microorganism specification, their numbers and functional properties [10]. Thirdly, there is
a cost consideration when it comes to commercial probiotic products, which may place daily probiotic
supplements out of the reach of many.
An alternative to consuming commercially-produced probiotic supplements for the maintenance
of a healthy gut microbiome is to alter one’s diet. It is increasingly accepted that the ‘Western-diet’,
characterised by highly-processed, low-fibre, high-sugar, high-fat foodstuffs has negative implications
for health [38], which may be mediated by an unfavourable impact on the gut microbiome [39].
In contrast, adherence to a Mediterranean-style diet (characterised by high-level consumption of olive
oil, fruit, nuts, vegetables, and cereals with moderate intake of fish and poultry) has been strongly
associated with better physical [40] and mental [41] health outcomes, which again may be related to
a beneficial impact on the gut microbiome and metabolome [42]. Gut microbiome composition can be
rapidly and significantly altered by introducing dietary change [43] with the impact of food choices on
the microbiome being highly individualised [11]. In this study, the key change in relation to dietary
intake during the 12-week residential course was an increase in dairy products, which in this context
were unpasteurised. This was a major change for our subjects, the vast majority of whom did not
consume unpasteurised milk or dairy products prior to the course.
Cow’s milk is produced on a massive scale worldwide and has long played an important role in
human nutrition [44]. Cow’s milk harbours a rich microbiota and typically contains a significant
population of lactic acid bacteria (LAB) that includes Lactococcus (8.2 × 101–1.4 × 104 CFU/mL),
Streptococcus (1.41 × 101–1.5 × 104 CFU/mL), Lactobacillus (1.0 × 102–3.2 × 104 CFU/mL), Leuconostoc
(9.8 × 101–2.5 × 103 CFU/mL) and Enterococcus spp. (2.57× 101–1.58× 103 CFU/mL) [45]. Other organisms
present in substantial proportions are Pseudomonas and Acinetobacter, so-called psychrotrophs which can
flourish during cold storage conditions and typically cause milk spoilage [46]. Pasteurisation of milk
gained widespread popularity in the early 1900s when cow’s milk was linked to the spread of disease
epidemics such as tuberculosis, diphtheria, typhoid fever, scarlet fever, anthrax and cholera [47]. A recent
Irish study, using molecular, culture-independent techniques, compared the microbial content of raw
and pasteurised cow’s milk [21]. Authors reported that, although the bacterial diversity of the raw
and pasteurised milk was similar, raw milk contained mostly viable cells whereas the cell population
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in pasteurised milk were predominantly nonviable. Thus, while pasteurised milk appeared to have
a somewhat similar microbiome composition to that of the raw milk, any potential probiotic LAB would
have been in a nonviable state. In this study, Pseudomonas and Acinetobacter, two major genera found
in unpasteurised milk, were not detected by 16S rRNA analysis of the microbiomes of the participants,
either pre or post treatment. This may be due to a selective filtering effect of the human immune system
or physiological barriers such as gastric acid, which is known to act as such a filter [48,49].
The consumption of raw milk is growing in popularity, although there is some debate in relation
to its purported benefits and concern about the potential dangers of contracting milk-borne illnesses
if the raw milk is contaminated with human pathogens [50]. There is a strong suggestion from
epidemiological literature that the consumption of unpasteurised cow’s milk or yoghurt by children
living on farms or rural areas has a protective effect against the development of asthma, allergies and
atopy, a finding that seems to be independent of other farm-related exposures [18]. In addition, raw milk
is anecdotally reported to be beneficial for people with lactose intolerance [51]. This is thought to be
due to the fact that raw milk contains high counts of LAB that produce lactase enzymes, which would
otherwise be destroyed during pasteurisation. However, there is little research evidence to support
these anecdotal claims and, in fact, one recent pilot randomised controlled trial (RCT) involving
16 adults with lactose malabsorption, failed to find any benefit of raw milk over pasteurised milk for
gastrointestinal symptoms [52]. Despite this, in a survey of raw-milk consumers [53], over one-third of
responders claimed to experience gastrointestinal discomfort from drinking pasteurised milk but no
discomfort after drinking raw milk, although the vast majority of these people did not have a diagnosis
of lactose intolerance. Another proposed benefit of raw milk is that it contains higher quantities of
vitamins. A meta-analysis [54] reported that pasteurisation reduced the concentrations of Vitamin E,
Vitamin B12, Vitamin B2, Vitamin C and folate. Of these vitamins, B2 is of most importance as bovine
milk contributes significantly to the recommended daily intake whereas in the case of all the others,
milk is not typically an important source. In relation to the human gut microbiome, we are unaware of
any studies specifically examining the effect of raw milk consumption. However, a few studies have
investigated the impact of pasteurised milk on the human microbiome. One cross-sectional study
reported a differential oral microbiome based on high versus low (pasteurised) milk intake [55]. Another
investigated the impact of whole milk supplementation on the gut microbiota and cardiometabolic
biomarkers between lactose malabsorbers (LM) and absorbers (LA) [56]. Authors found that whole
milk supplementation significantly altered the intestinal microbiota composition in LM, resulting
in an increase in the phylum Actinobacteria along with increases in several genera; Bifidobacterium,
Anaerostipes and Blautia. These changes occurred only in LM and not LA, suggesting that it was
the increased lactose substrate reaching the colon that preferentially enhanced the growth of some
microorganisms. In addition to pasteurisation, milk can be altered by skimming, which is currently
a widespread procedure. Prior to the course, 10/24 of our participants reported consuming skimmed
or semi-skimmed milk, while post-course, 23/24 participants consumed whole milk, reflecting the
unpasteurised milk intake. Skimmed milk contains less fat than whole milk and thus also less
fat-soluble vitamins such as A and E. However, regular unfortified milk is not a major contributor to
a person’s recommended daily allowance of these vitamins [57] and despite the variable amounts in
different milk types there does not appear to be a significant difference in their bioavailability [58].
Other micronutrients such as calcium, sodium and choline do not differ between skimmed and whole
milk [59]. Therefore, we considered the skimmed versus whole milk type to be of limited consequence.
An obvious limitation of this study is the inherent potential for confounding given that, in addition
to a change in diet, study participants experienced a change in environment. Disentangling the
impact of diet and geographical environment on the gut microbiome, however, is a very difficult
task. Several large scale studies have attempted to explore the differences in microbiome composition
between industrialised Western urban dwellers and those living in traditional rural communities in
South America and Africa, such as the Hadza hunter-gatherers of Tanzania [60], rural Papua New
Guineans [61], children from the rural African village of Burkina Faso [14] and communities from
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Malawi and Amazonian Amerindians [12]. Although a rural setting will likely contribute to gut
microbiome differences, these farming environments are intrinsically linked to variation in diet and it
is difficult to separate the impact of the farm environment itself and the farm-related dietary patterns.
If a move to a rural farming environment were to account for the changes in microbiome seen in our
study, one could postulate that the changes would be consistent with the microbiome composition
in rural dwellers from the above studies. This was not the case. While rural dwellers from PNG did
have higher abundance of Lactobacillus than their urban counterparts [61], those from the other rural
farming communities did not [14,60]. Obviously, the rural locations in the above studies were at the
extreme end in relation to geographical location and traditional lifestyle and poorly comparable to the
developed farm environment in which our participants were based. In a study more closely resembling
our location, authors compared the microbiome of infants from farming and non-farming families
in Wisconsin, United States, and again no differences in Lactobacillus or other LAB abundance were
seen [62]. Furthermore, the changes in bacterial taxa in the microbiome of our subjects were consistent
with those species found in unpasteurised milk, supporting our conclusion that this specific dietary
change was driving the microbiome differences between pre- and post-course time points.
In this study we found that, during the 12-week course, the levels of the faecal SCFA valerate
increased with a trend towards an increase in propionate. Straight-chain SCFAs (acetate, butyrate,
propionate and valerate) are produced by the gut microbiota during the fermentation of partially and
nondigestible polysaccharides whereas branched-chain SCFAs (isobutyrate and isovalerate) result
from the metabolism of proteins [63]. SCFAs are thought to play a major role in the maintenance of gut
and immune homeostasis [64] as well as in the gut-brain axis response to stress [65]. SCFA production
can be stimulated by increasing dietary fibre intake [66] or protein consumption [67]. However, in our
study, participants intake of fibre or protein did not change, and thus, it is proposed that increased
valerate and propionate levels may have been secondary to increased abundance of Lactobacilli, which,
along with other LAB, are known producers of SCFA [68]. Propionate has anti-inflammatory properties
and has been shown to be of potential benefit across a range of disorders, including hypertension and
cardiovascular disease [69], obesity [70] and hypercholesterolemia [71]. Valerate is a less well-known
SCFA with limited research to date into its therapeutic potential. However, a recent study revealed
that it also appears to have an immunomodulatory effect [72]. Interestingly, supplementation with
Lactobacillus acidophilus increased the concentration of valerate in the caecum of chickens infected
with Clostridium perfringens while reducing the infection-associated gut dysbiosis [73]. Valerate may
also hold some translatable therapeutic value in the context of Clostridium difficile infection (CDI).
Valerate was shown to be significantly reduced in the faecal samples of patients with recurrent CDI
and recovered following successful treatment with FMT [74].
Changes in the functionality of the microbiome were assessed in the context of a recent study
which facilitates analysis of the neuroactive potential of a microbiome sample [34]. Authors achieved
this using a gut–brain-module (GBM) framework, which targets microbial pathways known to be
involved in microbiota–gut–brain communication and have made this GBM catalogue available for
use by other researchers (https://raeslab.org/software/gbms.html). When applying our predictive
metagenomic data to this GBM catalogue, we found an increase in the functional richness of the
microbiome profile, as determined by the number of GBMs present, following the 12-week course
(Figure 4). Such a consistent general increase in GBMs without a significant increase in microbial alpha
diversity goes somewhat against the intuition that a more diverse microbial ecosystem will necessarily
display a higher functional diversity. More strikingly, the functional alpha diversity did not change
during the course. GBMs represent a specific subset of microbiome function and are calculated using
the values of specific KEGG Orthologues. A shift in microbial functions that specifically potentially
impact the host brain without a corresponding general shift in microbial function detectible on the
alpha diversity level shines light on the possibility that many more such specific shifts can occur
undetected using current bioinformatics tools. Because of this, we call for a move away from general
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diversity and towards informed interrogation of specific functional changes in the microbiome as
a readout.
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O e GBM c an ed significantly after post-hoc correction; ‘GBM026; Nitric oxide synthesis II
(nitrite reductase)’. Several studies have demonstrated the ability of various Lactobacillus species to
synthesise nitric oxide by nitrate reductase activity [75,76]. Nitric oxide is a complex and widespread
signalling molecule that participates in virtually every organ system of the body. It is thought to
play a role in the stress response and mood regulation [77] and may represent one mechanism by
which Lactobacilli exert psychobiotic effects. The authors believe another GBM warrants discussing
here, although its increase did not satisfy significance after post-hoc correction; ‘GBM004, Kynurenine
synthesis’. This module was never detected in participants pre-course but was present in very high
levels in 6 out of 24 participants post-course. This can be explained by the fact that the Kynurenine
synthesis module requires two enzymatic steps. One of these was found in Lactobacillus, but the other
one was not specific to a single microbe in this data set, but rather spread over several microbes and
was only found in the six participants positive for MBG004. This finding conforms well with literature
regarding the emergent biosynthetic capacity of the microbiome [78,79].
Although we found no direct correlation between Lactobacillus abundance and psychological
measures, it is notable that stress and anxiety levels reduced significantly in those with higher baseline
scores on the PSS and HADS-A. This is consistent with probiotic interventional trials in healthy
populations, whereby an impact is often only seen in those with higher anxiety or depression scores at
baseline [80,81]. Of course, there are many possible confounding factors when it comes to interpreting
this reduction. Participants in this course had varying reasons for completing the course; for some,
the purpose was to enhance or change their career options and, thus, possibly associated with stress;
for others it was simply for leisure and viewed more as a holiday incorporating cookery classes.
The change in environment and daily activity, the purpose of participation in the course and interaction
with new people may all have contributed to psychological status. However, given the increasing
evidence that the gut microbiome is an important node in gut–brain communication and that certain
psychobiotics have anxiolytic effects, it is plausible to consider the possibility that the improvement
in stress and anxiety may have been partially related to the increase in Lactobacillus. Lactobacillus
rhamnosus (JB-1) has been shown to reduce anxiety behaviours in mice as well as altering central levels
of gamma-aminobutyric acid [82], a key neurotransmitter in anxiety regulation. Several species of
Lactobacillus have demonstrated the ability to reduce anxiety and stress levels in healthy subjects [83–85]
as well as in patients with chronic fatigue syndrome [86] or laryngeal cancer [87].
Nutrients 2020, 12, 1468 16 of 21
There are several limitations to our study. Firstly, this was an observational study. While of
course an RCT would be preferable, there are many challenges inherent in designing RCTs involving
dietary interventions. It can be difficult to define appropriate control groups and effective blinding
of participants and investigators is often extremely difficult [88]. In particular, it can be challenging
to accomplish a high level of adherence with whole food, or dietary pattern, interventions. A major
strength of our study in this regard was that our participants were based on-site for the entire duration
of the study making it possible to ensure a consistency across individual diets, which would be difficult
to achieve outside a residential setting. The potential confounding effect of the farm environment
as an independent modulator of microbiome composition is addressed earlier in the discussion.
Secondly, our sample size was quite small. However, previously published studies investigating
the diet–microbiome relationship have involved participant numbers of ten or less [43,89] and have
generally been of much shorter duration [11]. Another factor that may limit the generalizability
of our study was that participants undertaking this course were interested in food and cooking.
Thus, they were likely to have good nutritional knowledge and possibly healthier than average diets
at baseline. A specific limitation in this regard was an absence of any information on the use of
non-nutritive sweeteners (NNS). These are being increasingly used due to the concern about the negative
health impact of high-sugar diets and have been shown to significantly, and generally negatively,
impact the gut microbiome [90]. Finally, given the limitations of 16S rRNA gene sequencing we were
unable to characterise organisms beyond the genus level. More accurate taxonomic classification would
have been useful had shotgun metagenomic sequencing been performed. Despite these limitations,
this is, to our knowledge, the first study to report on the potential impact of unpasteurised milk and
dairy products on the human gut microbiome.
5. Conclusions
While there are understandable concerns in relation to potential contamination and safety when
it comes to unpasteurised milk, it is a rich source of probiotic bacteria. Abundances of Lactobacilli
increased significantly following a 12-week dietary change, which involved the consumption of
unpasteurised milk and dairy products by participants. Lactococcus abundance also increased, although
to a lesser extent. These changes in microbiome composition were reflected by an increase in levels
of the SCFA, valerate with an observed trend towards an increase of propionate, along with an
increase in the predicted functional richness of the microbiome. While there was no overall change in
psychological measures, stress and anxiety scores did decrease in those with higher baseline scores.
Given the growing appreciation of the importance of a healthy gut microbiome and the limitations of
commercial probiotic products, there is a need for further research into the effect of different dietary
changes on the microbiome and subsequent mental health. In particular, the consumption of raw milk
and other probiotic-rich fermented foods is growing in popularity and it is important that the effect of
such products on the gut microbiome are investigated.
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